173rd Meeting of the ACNFP 24th and 25th September 2025 Agenda

ACNFP/AG/173

Advisory Committee on Novel Foods and Processes

The 173^rd meeting of the ACNFP will be held as a two-day event at 10:00am on the 24^th and 25^th of September 2025 at The Wesley Hotel & Conference Venue, Euston House, 81-103 Euston Street, London, NW1 2EZ by invite only and on Microsoft Teams (online & dial in).

Members are reminded of the need to announce any commercial interests in the business of the Committee prior to the discussions on each item.

In accordance with agreed procedures, the Secretariat is duty bound to keep a record of the names of Members who have declared interests at meetings of the Committee, giving dates, names of relevant products and companies, details of the interest declared, and whether the Member took part in the proceedings.

ACNFP Secretariat

August 2025

173rd Meeting of the ACNFP - 24th September 2025 (Day 1) Agenda

1. Apologies and Announcements

2. Welcome    

3. 172^nd Meeting Minutes

4. Matters Arising

5. Urolithin A RP1777 - The Committee will review this full novel food application for the first time and identify key considerations for the assessment and any data gaps. ACNFP/173/02

6. CBD RP47 (reserved business) - The Committee will review the dossier for the first time along with a draft Committee Advice Document. ACNFP/173/03

7. CBD RP46 (reserved business) - The Committee will review the dossier for the first time along with a draft Committee Advice Document. ACNFP/173/04

8. Introduction to Group C CBD applications (reserved business) - the Committee will be introduced to the assessment of applications for hemp extracts with a significant amount of CBD present (group C) under the novel food regulation. ACNFP/173/05

9. CBD RP225 (reserved business) - The Committee will review the dossier for the first time along with a draft Committee Advice Document. ACNFP/173/06

10. Items for Information

    10.1 Update from Novel Foods Policy Team

    10.2 Update from GM Policy Team

    10.3 SACs update

11. AOB

25th September 2025 (Day 2) Agenda

12. Workshop on Cell Cultivated Products (CCP) (reserved business) – The Committee will provide feedback on draft FSA guidance for applicants on nutrition and allergenicity assessment tailored for Cell Cultivated Products (CCPs) within the novel food framework. ACNFP/173/07

13. Clostridium tyrobutyricum ‘Clostridium Protein’ RP1920 - The Committee will review this full novel food application for the first time and identify key considerations for the assessment and any data gaps. ACNFP/173/08

14. Lyso-phosphatidylcholine (LPC)-rich oil from Antarctic krill (Euphausia superba) RP2181 - The Committee will review this full novel food application for the first time and identify key considerations for the assessment and any data gaps. ACNFP/173/09

15. GMB151 x DAS-44406-6 soybean RP2246 (reserved business) - The Committee will review the draft safety assessment outcome developed and agreed by the PGT Subcommittee. ACNFP/173/10

Date of next meeting – 19^th November 2025